Half-year Report
RNS Number : 3016Z
Windar Photonics PLC
15 September 2025
15 September 2025
("Windar", the "Company" or the "Group")
Interim Results
Demand Broadening and On Track to Deliver for FY25
Windar Photonics plc (AIM: WPHO), the technology group that has developed its WindEye and WindTimizer LiDAR wind sensors and its related Nexus OS software suite designed to efficiently and cost effectively increase the power output and reduce lifetime operating costs of electricity generating wind turbines, today announces its unaudited results for the 6 months ended 30 June 2025.
H1 2025 Highlights
Financial:
| · Revenue up 18% to €2.7m (H1 2024: €2.3m) which with a strong concentration of upcoming sales in Q3 and Q4, makes the Company well placed for FY25. |
| · Continued gross margin progression of +2%-points vs. H1 2024 as first software revenues are reflected and the focus on profitability is maintained. |
| · EBITDA loss (before warrant / share-based payments) of €0.2m (H1 2024 loss: €0.1m). EBITDA was impacted negatively (€0.4) by strategic decision to increase marketing investment. |
| · Loss after tax of €0.7m (H1 2024: €0.3m). |
| · Basic loss per share of €0.01ps (H1 2024: €0.004ps). |
| · Strong cash position to support future investment of €6.0m as at 30 June 2025 (H1 2024: €2.8m). |
| · Adverse currency effects with €0.5m loss in H1 following relative sterling weakness and the impact from main revenue generating currencies down by 8-9% compared to end 2024. |
| · COGS at the end of period reduced by 15% compared to end of 2024 which offsets the negative currency impacts in coming periods. |
| · Demand is broadening alongside the increased investment in marketing the Company's expanding product range: |
| o Optimization solution now controls more than 20% of all installed Vestas V82s in North America as per end of June 2025 |
| o Increased potential sales activity in North America and Asia (outside China) with discussions and a number of test projects underway on a broad number of turbine platforms. |
| o First direct test project (no distributor in chain) started on a major Goldwind wind farm in China. |
| o All of which supports additional growth in 2026 and beyond |
| · Significant investment in people, product development and manufacturing capacity to scale the business to match market opportunity |
| · Excellent customer feedback from the Cleanpower fair in Phoenix, with interest in both our turbine optimization solutions and upcoming launch of the Nexus TPM module (Turbine Performance Monitoring). |
| · End of June the Company moved into new manufacturing facilities in Copenhagen enabling a potential quintupling of production capacity. |
| · As with wider markets, the introduction of import tariffs into North America, created initial uncertainty and slowed decision making. More recently however, the Company has seen normal business resume, as evidenced by the significant North American contract signed in August. |
| · In H1 2025, the Company delineated its service offerings into the following two categories: |
| · In August, the Company won a significant US order for US$2.6m, under the new import tariff and tax credit regime, to retrofit Vestas V82s in Q3 2025 whereby our optimization solution will control more than 25% of all V82 turbines in North America when installed. |
| · First test result from above mentioned direct test project in China already proved substantial potential power gains with increased expectations to convert into a major order in the near future. |
| · New VP of Sales for Americas hired in September with main focus on targeting the remaining 75% V82 turbines in North America still not controlled by our Optimization solution and further expanding our solution into new turbine platforms. |
| · New VP of Sales for Europe hired in August in order to basically initiate sales activities in the region. |
| · Vestas Multibrand Service (APAC region) agreed to market our solutions broadly in the Asian region including in China. |
| · Despite currency headwinds and initial uncertainty caused by tariffs, the Company is well placed, with orders for delivery in H2 2025 of €3.6m as of August 2025 further supported by the pipeline and the above strengthening of our sales organization, to meet full year market expectations. |
| Windar Photonics plc | |
| Jørgen Korsgaard Jensen, CEO | Tel: +45 24234930 |
| Grant Thornton UK LLP Nominated Adviser | |
| Philip Secrett / Harrison Clarke / Elliot Peters | Tel: +44 (0) 20 7383 5100 |
| Dowgate Capital Broker | |
| James Serjeant / Russell Cook | Tel: +44 (0) 20 3903 7715 |
| Novella Communications | |
| Tim Robertson / Safia Colebrook | Tel: +44 (0) 20 3151 7008 |
| CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||||
| Six months ended30 June 2025 | Six months ended 30 June 2024 | Year ended 31 December 2024 | ||
| (unaudited) | (unaudited) | (audited) | ||
| Note | € | € | € | |
| Revenue | 2,716,609 | 2,296,781 | 4,560,515 | |
| Cost of goods sold | (1,033,748) | (907,577) | (1,990,513) | |
| Gross profit | 1,682,861 | 1,389,204 | 2,570,002 | |
| Administrativeexpenses | (2,172,816) | (1,623,482) | (3,433,049) | |
| Other operating income Exceptional (expenses)/income | - - | - - | - (221,557) | |
| Loss from operations | (489,955) | (234,278) | (1,084,604) | |
| Finance income | 132,347 | - | 38,225 | |
| Finance expenses | (558,307) | (30,528) | (75,651) | |
| Loss before taxation | (915,915) | (264,806) | (1,122,030) | |
| Taxation | 186,586 | (32,016) | 215,840 | |
| Loss for the period | (729,329) | (296,822) | (906,190) | |
| Other comprehensive income | ||||
| Items that will or maybe reclassified to profit or loss: | ||||
| Exchange losses arising on translation of foreign operations | (135,956) | (17,664) | (35,757) | |
| Total comprehensive loss for the period | (865,285) | (314,569) | (941,947) | |
| Loss per share for loss attributable to the ordinary equity holders of Windar Photonics plc | ||||
| Basic and diluted, cents per share | 2 | (0.8) | (0.4) | (1,1) |
| As at 30 June 2025 | As at 30 June 2024 | As at 31 December 2024 | ||
| (unaudited) | (unaudited) | (audited) | ||
| Notes | € | € | € | |
| Assets | ||||
| Non-current assets | ||||
| Intangible assets | 1,573,993 | 1,559,198 | 1,764,959 | |
| Property, plant & equipment Right of use asset | 716,428 13,090 | 290,531 42,415 | 419,069 28,839 | |
| Deposits | 93,694 | 40,059 | 40,684 | |
| Total non-current assets | 2,397,205 | 1,932,203 | 2,253,551 | |
| Current assets | ||||
| Inventory | 3 | 1,856,835 | 1,037,619 | 1,361,581 |
| Trade receivables | 4 | 1,730,514 | 1,265,083 | 4,304,399 |
| Other receivables | 4 | 449,579 | 224,109 | 242,011 |
| Tax credit receivables | 4 | 432,928 | 118,999 | 246,377 |
| Prepayments | 195,728 | 10,387 | 164,866 | |
| Cash and cash equivalents | 6,030,175 | 2,763,637 | 7,066,338 | |
| Total current assets | 10,695,759 | 5,419,834 | 13,385,572 | |
| Total assets | 13,092,964 | 7,352,037 | 15,639,123 | |
| Equity | ||||
| Share capital | 5 | 1,167,248 | 985,971 | 1,163,251 |
| Share premium | 27,808,122 | 21,203,127 | 27,635,201 | |
| Merger reserve | 2,910,866 | 2,910,866 | 2,910,866 | |
| Foreign currency reserve | (230,201) | (76,152) | (94,245) | |
| Accumulated loss | (21,350,852) | (20,148,553) | (20,663,066) | |
| Total equity | 10,305,183 | 4,875,259 | 10,952,007 | |
| Non-current liabilities | ||||
| Warranty provisions Holiday Allowance provision Right of use liablility | 6 | 36,993 148,803 - | 28,160 140,599 - | 36,997 142,697 - |
| Loans | 6 | 709,305 | 1,173,230 | 804,822 |
| Total non-current liabilities | 895,101 | 1,341,989 | 984,516 | |
| Current liabilities | ||||
| Trade payables | 7 | 490,650 | 56,120 | 395,386 |
| Other payables and accruals | 7 | 713,740 | 466,501 | 650,248 |
| Contract liabilities | 7 | 204,838 | 128,270 | 1,809,370 |
| Right of use liability | 7 | 13,734 | 43,783 | 30,257 |
| Provisions | 7 | - | - | 221,557 |
| Loans | 7 | 469,718 | 440,115 | 595,782 |
| Total current liabilities | 1,892,681 | 1,134,789 | 3,702,600 | |
| Total liabilities | 2,787,782 | 2,476,778 | 4,687,116 | |
| Total equity and liabilities | 13,092,964 | 7,352,037 | 15,639,123 |
| CONSOLIDATED CASH FLOW STATEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 | |||
| Six months ended30 June 2025 | Six months ended30 June 2024 | Year ended 31 December 2024 | |
| (unaudited) | (unaudited) | (audited) | |
| € | € | € | |
| Loss for the period before tax | (915,915) | (264,806) | (1,122,030) |
| Adjustments for: | |||
| Finance expenses | 425,960 | 30,528 | 37,426 |
| Amortisation | 176,234 | 48,480 | 269,578 |
| Depreciation - property, plant and equipment Depreciation - right of use assets | 42,630 13,888 | 34,721 14,091 | 40,808 28,236 |
| Received tax credit | - | - | 246,413 |
| Taxes paid Foreign exchange difference | - (135,956) | - (17,664) | 1,344 (35,757) |
| Share option and warrant cost | 41,543 | 49,645 | 144,500 |
| (351,616) | (105,005) | (389,482) | |
| Movements in working capital | |||
| Changes in inventory | (495,255) | (318,636) | (642,598) |
| Changes in receivables | 2,366,317 | (807,832) | (3,865,050) |
| Changes in prepayments | (30,861) | 119,164 | (35,316) |
| Changes in deposits | (53,010) | (1,796) | (2,422) |
| Changes in trade payables | 95,264 | (516,112) | (176,846) |
| Changes in contract liabilities | (1,604,532) | (123,408) | 1,557,692) |
| Changes in warranty provision | (4) | 2,663 | 11,504 |
| Changes in other payables and provision | (158,064) | (6,307) | 398,995 |
| Cash flow (used in) operations | (231,761) | (1,757,269) | (3,143,523) |
| Investing activities | |||
| Payments for intangible assets Payments for tangible assets | (136,310) (192,555) | (273,893) - | (573,093) (277,422) |
| Grants received | - | 13,967 | 29,894 |
| Cash flow (used in) investing activities | (328,865) | (259,926) | (820,621) |
| Financing activities | |||
| Proceeds from issue of share capital | 176,917 | 5,394,280 | 12,340,702 |
| Costs associated with the issue of share capital | - | (519,104) | (856,171) |
| Lease payments | (15,299) | (15,534) | (29,625) |
| Repayment of loans | (211,409) | (203,076) | (530,280) |
| Interest (paid)/received | (425,231) | (29,168) | (34,535) |
| Cash flow from financing activities | (475,022) | 4,627,398 | 10,890,091 |
| Net (decrease)/increase in cash and cash equivalents | (1,035,648) | 2,610,203 | 6,925,947 |
| Exchange differences | (516) | 1,254 | (11,789) |
| Cash and cash equivalents at the beginning of the period | 7,066,338 | 152,180 | 152,180 |
| Cash and cash equivalents at the end of the period | 6,030,174 | 2,763,637 | 7,066,338 |
| Share Capital | Share Premium | Merger reserve | Foreign currency reserve | Accumulated Losses | Total | |
| € | € | € | € | € | € | |
| At 1 January 2024 | 834,771 | 16,479,150 | 2,910,866 | (58,488) | (19,901,376) | 264,923 |
| New shares issued | 151,200 | 5,085,736 | - | - | - | 5,236,936 |
| Share option and warrant costs | - | (361,759) | - | - | - | (361,759) |
| Transaction with owners | 151,200 | 4,723,977 | - | - | - | 4,875,177 |
| Comprehensive loss for the period | - | - | - | - | (296,822) | (296,822) |
| Warant reserve | 49,645 | 49,645 | ||||
| Other comprehensive loss | - | - | - | (17,664) | - | (17,664) |
| Total comprehensive income | - | - | - | (17,664) | (247,177) | (264,841) |
| At 30 June 2024 | 985,971 | 21,203,127 | 2,910,866 | (76,152) | (20,148,553) | 4,875,259 |
| New shares issued | 177,280 | 6,926,486 | - | - | - | 7,103,766 |
| Costsassociated withcapitalraise | - | (494,412) | - | - | - | (494,412) |
| Transaction with owners | 177,280 | 6,432,074 | - | - | - | 6,609,354 |
| Comprehensive loss for the period | - | - | - | - | (609,368) | (609,368) |
| Warrants reserve | - | - | - | - | 94,855 | 94,855 |
| Other comprehensive income | - | - | - | (18,093) | - | (18,093) |
| Total comprehensive income | - | - | - | (18,093) | (514,513) | (532,606) |
| At 31 December 2024 | 1,163,251 | 27,635,201 | 2,910,866 | (94,245) | (20,663,066) | 10,952,007 |
| New shares issued | 3,997 | 172,921 | - | - | - | 176,918 |
| Share option and warrant costs | - | - | - | - | - | - |
| Transaction with owners | 3,997 | 172,921 | - | - | - | 176,918 |
| Comprehensive loss for the period | - | - | - | - | (729,329) | (729,329) |
| Warrant reserve | - | - | - | - | 41,543 | 41,543 |
| Other comprehensive Income | - | - | - | (135,956) | - | (135,956) |
| Total comprehensive loss | - | - | - | (135,956) | (770,872) | (823,742) |
| At 30 June 2025 | 1,167,248 | 27,808,122 | 2,910,866 | (230,201) | (21,350,852) | 10,305,183 |
| Six months ended30 June 2025 | Six months ended30 June 2024 | Year ended 31 December 2024 | |
| Loss for the period (€) | (729,329) | (296,822) | (906,190) |
| Weighted average number of ordinary shares for the purpose of basic earnings per share | 96,367,826 | 81,287,870 | 78,937,487 |
| Basic loss and diluted, cents per share | (0.8) | (0.4) | (1.1) |
| As at 30 June 2025 | As at 30 June 2024 | As at 31 December 2024 | |
| € | € | € | |
| Raw materials | 981,208 | 714,571 | 484,493 |
| Work in progress | 154,198 | 92,480 | 79,904 |
| Finished goods | 721,429 | 230,568 | 797,194 |
| Inventory | 1,856,8353 | 1,037,619 | 1,361,581 |
| As at 30 June 2025 | As at 30 June 2024 | As at 31 December 2024 | |
| € | € | € | |
| Trade receivables | 1,730,514 | 1,265,083 | 4,304,399 |
| Less; provision for impairment of trade receivables | - | - | - |
| Trade receivables - net | 1,730,514 | 1,265,083 | 4,304,399 |
| Total financial assets other than cash and cash equivalents classified at amortized costs | 1,730,514 | 1,265,083 | 4,304,399 |
| Tax receivables | 432,928 | 118,999 | 246,377 |
| Other receivables | 449,579 | 224,109 | 242,011 |
| Total other receivables | 882,507 | 343,108 | 488,388 |
| Total trade and other receivables | 2,613,021 | 1,608,191 | 4,792,787 |
| Classified as follows: Current Portion | 2,613,021 | 1,608,191 | 4,792,787 |
| Number of shares | € | |
| Shares as 30 June 2024 | 81,287,870 | 834,771 |
| Issue of shares for cash | 14,750,000 | 328,480 |
| Shares at 31 December 2024 | 96,037,870 | 1,163,251 |
| Issue of shares for cash | 329,956 | 3,997 |
| Shares at 30 June 2025 | 96,367,826 | 1,167,248 |
| Six months ended30 June 2025 | Six months ended30 June 2024 | Year ended 31 December 2024 | |
| € | € | € | |
| Growth Fund Loans (including accrued interest) | 1,179,023 | 1,613,345 | 1,400,604 |
| Current portion of Growth Fund Loans | (469,718) | (440,115) | (595,782) |
| Holiday Accruals | 148,803 | 140,599 | 142,697 |
| Total non-current financial liabilities measured at amortised costs | 858,108 | 1,313,829 | 947,519 |
| As at 30 June 2025 | As at 30 June 2024 | As at 31 December 2024 | |
| € | € | € | |
| Trade payables | 490,650 | 56,120 | 395,386 |
| Other payables and accruals | 628,063 | 362,823 | 438,042 |
| Payables to Directors | 85,677 | 103,678 | 212,206 |
| Right of use liability | 13,734 | 43,783 | 30,257 |
| Current portion of loans | 469,718 | 440,115 | 595,782 |
| Total financial liabilities, excluding´non- current´ loans and borrowings classified as financial liabilities measured at amortized cost | 1,687,842 | 1,006,519 | 1,671,673 |
| Contract liabilities | 204,838 | 128,270 | 1,809,370 |
| Total trade and other payables | 1,892,680 | 1,134,789 | 3,481,043 |
| Classified as follows: Current Portion | 1,892,680 | 1,134,789 | 3,481,043 |